Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
berotralstat desogestrel-containingcontraceptives

decreases efficacy

Unknown Theoretical
berotralstat ergotamine

increases exposure

Unknown Study
berotralstat pimozide

increases exposure

Unknown Study
berotralstat tacrolimus

increases exposure

Unknown Study
beta 2agonists ipratropium

increases risk of glaucoma

Unknown Anecdotal
betablockers,non-selective relugolix

increases exposure

Unknown Theoretical
betablockers,selective adrenalineepinephrine

increases risk of k hypertensionandbradycardia

Unknown Study
betablockers,selective adrenalineepinephrine

increases risk of hypertensionandbradycardia

Unknown Study
betablockers,selective ergometrine

increases risk of peripheralvasoconstriction

Unknown Study
betablockers,selective ergotamine

increases risk of peripheralvasoconstriction

Unknown Study
betablockers,selective lanreotide

increases risk of bradycardia

Unknown Theoretical
betablockers,selective noradrenalinenorepinephrine

increases risk of k hypertensionandbradycardia

Unknown Study
betablockers,selective noradrenalinenorepinephrine

increases risk of hypertensionandbradycardia

Unknown Study
betablockers,selective sympathomimetics,vasoconstrictor

increases risk of k hypertensionandbradycardia

Unknown Study
betablockers,selective sympathomimetics,vasoconstrictor

increases risk of hypertensionandbradycardia

Unknown Study
bezafibrate ciclosporin

increases risk of nephrotoxicity

Unknown Theoretical
bicalutamide lomitapide

increases exposure

Unknown Theoretical
bictegravir metformin

increases exposure

Unknown Study
bictegravir methadone

increases exposure

Unknown Theoretical
bictegravir opioids

increases exposure

Unknown Theoretical
bimekizumab coumarins

affects exposure

Unknown Theoretical
bimekizumab warfarin

affects exposure

Unknown Theoretical
bismuthsubsalicylate drugswithanticoagulanteffects

increases risk of bleedingevents

Unknown Theoretical
bismuthsubsalicylate seetablep

increases risk of bleedingevents

Unknown Theoretical
bisphosphonates deferasirox

increases risk of gastrointestinalbleeding

Unknown Theoretical
bisphosphonates ironchelators

increases risk of gastrointestinalbleeding

Unknown Theoretical
bosentan acalabrutinib

decreases exposure

Unknown Study
bosentan anti-androgens

decreases efficacy

Unknown Study
bosentan antiarrhythmics

decreases exposure

Unknown Theoretical
bosentan atorvastatin

decreases exposure

Unknown Study
bosentan avacopan

decreases exposure

Unknown Theoretical
bosentan avapritinib

decreases exposure

Unknown Study
bosentan axitinib

decreases exposure

Unknown Study
bosentan bedaquiline

decreases exposure

Unknown Study
bosentan bosutinib

decreases exposure

Unknown Study
bosentan brigatinib

decreases exposure

Unknown Study
bosentan cabazitaxel

decreases exposure

Unknown Theoretical
bosentan cabozantinib

decreases exposure

Unknown Study
bosentan ceritinib

decreases exposure

Unknown Study
bosentan cobicistat

decreases exposure

Unknown Theoretical
bosentan cobimetinib

decreases exposure

Unknown Theoretical
bosentan combinedhormonalcontraceptives

decreases efficacy

Unknown Study
bosentan coumarins

decreases anticoagulant effect

Unknown Study
bosentan crizotinib

decreases exposure

Unknown Study
bosentan cyproterone

decreases efficacy

Unknown Study
bosentan dabrafenib

decreases exposure

Unknown Study
bosentan dasatinib

decreases exposure

Unknown Study
bosentan desogestrel

decreases efficacy

Unknown Theoretical
bosentan diltiazem

decreases exposure

Unknown Theoretical
bosentan docetaxel

decreases exposure

Unknown Theoretical
Prev 1 ... 6 7 8 9 10 ... 79 Next
3916 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.